Showing results (451-460 of 621) with videos related to
Sort By:
Pageof 63
Thrombosis Research|January 1, 1986
The influence of preadsorbed canine von Willebrand factor, fibronectin and fibrinogen on ex vivo artificial surface-induced thrombosisL K Lambrecht, B R Young, R E Stafford, et al.Journal of Pharmaceutical Sciences|January 20, 2011
Histamine release associated with intravenous delivery of a fluorocarbon-based sevoflurane emulsion in caninesRebecca A Johnson, Ken T Simmons, Jonathan P Fast, et al.Journal of Human Hypertension|July 23, 2003
Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study populationJ R Ortlepp, J Metrikat, V Mevissen, et al.Prehospital Emergency Care|June 30, 2017
Out-of-hospital and Inter-hospital Under-triage to Designated Tertiary Trauma Centers among Injured Older Adults: A 10-year Statewide Geospatial-Adjusted AnalysisTabitha Garwe, Kenneth Stewart, Julie Stoner, et al.The American Surgeon|June 18, 2011
Defining incidence and outcome of contrast-induced nephropathy among trauma: is it overhyped?Narong Kulvatunyou, Peter M Rhee, Steven N Carter, et al.Neurology|December 1, 1994
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapseP Rieckmann, S Martin, I Weichselbraun, et al.Physical Review Letters|January 3, 2001
Ferromagnetic hcp chromium in Cr/Ru(0001) superlatticesM Albrecht, M Maret, J Kohler, et al.Journal of Telemedicine and Telecare|November 14, 2023
Demographic and socioeconomic disparities in the hybrid ophthalmology telemedicine modelManal Dia, Samaneh Davoudi, Nedda Sanayei, et al.Klinische Padiatrie|July 4, 2003
Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlookW Dörffel, H Lüders, U Rühl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial GroupM Kaufmann, W Jonat, U Kleeberg, et al.Pageof 63